Ankylosing spondylitis epidemiology and demographics

Jump to: navigation, search

Ankylosing spondylitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ankylosing spondylitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ankylosing spondylitis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ankylosing spondylitis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ankylosing spondylitis epidemiology and demographics

CDC on Ankylosing spondylitis epidemiology and demographics

Ankylosing spondylitis epidemiology and demographics in the news

Blogs on Ankylosing spondylitis epidemiology and demographics</small>

Directions to Hospitals Treating Ankylosing spondylitis

Risk calculators and risk factors for Ankylosing spondylitis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S[2]

Overview

The prevalence of axial spondyloarthritis (axSpA) or ankylosing spondylitis in a population depends upon the following 1)Ethnic groups 2) Selection of subjects for evaluation and 3) The criteria for diagnosis.It shows a clear evidence that correlation between the prevalence of ankylosing spondylitis (AS)/axial spondyloarthritis (axSpA) in a given population and the prevalence of human leukocyte antigen HLA-B27 exits.

Epidemiology and Demographics

Prevalence

  • The prevalence of ankylosing spondylitis is approximately 7-490 per 100,000 individuals worldwide.[1][2]
  • In the year 2009, according to National Health and Nutrition Examination Survey (NHANES) the incidence of ankylosing spondylitis was estimated to be 6.1% cases per 100,000 individuals worldwide.

Incidence[3][4][5] 

  • The incidence of fractures in ankylosing spondylitis is approximately  4 to 18 percent .
  • The incidence of ankylosing spondylitis is approximately 6–7 per 100,000 persons in caucasian populations.

Mortality rate [6][7]

Age[8][9]

Race[10]

  • Ankylosing spondylitis(AS) usually affects individuals of the North America race. Japan individuals are less likely to develop ankylosing spondylitis(AS).

Gender[11]

  • Men are more commonly affected by Ankylosing spondylitis(AS) than women. The men to women ratio is approximately 2:1.

References

  1. Reveille JD, Weisman MH (June 2013). "The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States". Am. J. Med. Sci. 345 (6): 431–6. PMC 4122314Freely accessible. PMID 23841117. 
  2. Bakland, Gunnstein; Nossent, Hans C.; Gran, Jan T. (2005). "Incidence and prevalence of ankylosing spondylitis in Northern Norway". Arthritis & Rheumatism. 53 (6): 850–855. ISSN 0004-3591. doi:10.1002/art.21577. 
  3. Mundwiler ML, Siddique K, Dym JM, Perri B, Johnson JP, Weisman MH (2008). "Complications of the spine in ankylosing spondylitis with a focus on deformity correction". Neurosurg Focus. 24 (1): E6. PMID 18290744. doi:10.3171/FOC/2008/24/1/E6. 
  4. Bakland, Gunnstein; Nossent, Hans C.; Gran, Jan T. (2005). "Incidence and prevalence of ankylosing spondylitis in Northern Norway". Arthritis & Rheumatism. 53 (6): 850–855. ISSN 0004-3591. doi:10.1002/art.21577. 
  5. Vosse D, Feldtkeller E, Erlendsson J, Geusens P, van der Linden S (October 2004). "Clinical vertebral fractures in patients with ankylosing spondylitis". J. Rheumatol. 31 (10): 1981–5. PMID 15468363. 
  6. Oh JS, Doh JW, Shim JJ, Lee KS (June 2016). "Leading a Patient of Ankylosing Spondylitis to Death by Iatrogenic Spinal Fracture". Korean J Spine. 13 (2): 80–2. PMC 4949174Freely accessible. PMID 27437020. doi:10.14245/kjs.2016.13.2.80. 
  7. Bakland G, Gran JT, Nossent JC (November 2011). "Increased mortality in ankylosing spondylitis is related to disease activity". Ann. Rheum. Dis. 70 (11): 1921–5. PMID 21784726. doi:10.1136/ard.2011.151191. 
  8. Pradeep, D. J.; Keat, A.; Gaffney, K. (2008). "Predicting outcome in ankylosing spondylitis". Rheumatology. 47 (7): 942–945. ISSN 1462-0324. doi:10.1093/rheumatology/ken195. 
  9. Montilla C, Del Pino-Montes J, Collantes-Estevez E, Font P, Zarco P, Mulero J, Gratacós J, Rodríguez C, Juanola X, Fernández-Sueiro JL, Almodovar R (May 2012). "Clinical features of late-onset ankylosing spondylitis: comparison with early-onset disease". J. Rheumatol. 39 (5): 1008–12. PMID 22422491. doi:10.3899/jrheum.111082. 
  10. Reveille JD (April 2011). "Epidemiology of spondyloarthritis in North America". Am. J. Med. Sci. 341 (4): 284–6. PMC 3063892Freely accessible. PMID 21430444. doi:10.1097/MAJ.0b013e31820f8c99. 
  11. Pradeep, D. J.; Keat, A.; Gaffney, K. (2008). "Predicting outcome in ankylosing spondylitis". Rheumatology. 47 (7): 942–945. ISSN 1462-0324. doi:10.1093/rheumatology/ken195. 

Linked-in.jpg